Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 363, 182-187
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A nationwide survey of combined central and peripheral demyelination in JapanJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Anti-neurofascin antibody in patients with combined central and peripheral demyelinationNeurology, 2013
- International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsMultiple Sclerosis Journal, 2013
- Postinfectious neurologic syndromesNeurology, 2013
- Autoimmune disorders affecting both the central and peripheral nervous systemAutoimmunity Reviews, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literatureJournal of Neurology, Neurosurgery & Psychiatry, 2010
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First RevisionJournal of the Peripheral Nervous System, 2010
- Acute Combined Central and Peripheral Nervous System Demyelination in ChildrenPediatric Neurology, 2008
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple SclerosisNew England Journal of Medicine, 2008